Clinical Trials Browser

INDUSTRY × Serotonin Syndrome × Clear all

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Phase 2 Active not recruiting

36 enrolled 19 charts

EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT03223428 2024-07-24

RELAX

Completed

223 enrolled 16 charts

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

EndocrineNET

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT01234168 2020-11-05

SYMNET

Completed

340 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT00092287 2020-04-30

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase 3 Terminated

4 enrolled

Endocrine

Malignant Carcinoid Syndrome, Serotonin Syndrome

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT00088595 2012-06-04

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Phase 2 Completed

45 enrolled 10 charts

Endocrine

Carcinoid Tumor, Serotonin Syndrome

Clinical Trials

CAREFNDR

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

RELAX

ELECT

SYMNET

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors